A Study of Canagliflozin and Metformin Immediate Release (150 mg/500 mg) FDC Tablets in Healthy Volunteers

NCT01508182 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Canagliflozin tablets
DRUG: Metformin IR tablets
DRUG: Canagliflozin/metformin IR FDC tablets
DRUG: Canagliflozin tablets
DRUG: Metformin IR tablets
DRUG: Canagliflozin/metformin IR FDC tablets

Sponsor

Janssen Research & Development, LLC